Biallelic variants in RNU2-2 cause the most prevalent known recessive neurodevelopmental disorder
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
We recently showed that mutations in the snRNA genes RNU4-2 and RNU2-2 are prevalent causes of dominant neurodevelopmental disorders (NDDs). Here, by genetic association, we demonstrate the existence of a recessive form of RNU2-2 syndrome. We inferred a log Bayes factor for a recessive model of association of 18.2. Conditional on that model, 17 rare variants had a posterior probability of pathogenicity >0.8. This conservative threshold identified 18 probands and 5 affected siblings, each carrying two alleles in trans at these variants. A relaxed threshold of >0.6 identified a further 13 candidate probands. We identified nine further cases in replication collections. Affected individuals have intellectual disability, global developmental delay and seizures. Recessive RNU2-2 syndrome accounts for ~10% of families with a recessive NDD presently diagnosable by sequencing and affects ~60% as many families as the dominant RNU4-2-related NDD ReNU syndrome. The variants are predicted to destabilize stem loops and binding domains of U2-2 snRNA. Whole-blood RNA sequencing data showed a >90% reduction in the expression of pathogenic U2-2 alleles in biallelic cases and monoallelic carriers, albeit with wild-type compensation in carriers, pointing to a loss-of-expression mechanism.
Description
Acknowledgements: This research was made possible through access to data in the NGRL, which is managed by Genomics England Limited (a wholly owned company of the Department of Health and Social Care). The NGRL holds data provided by patients and collected by the NHS as part of their care and data collected as part of their participation in research. The NGRL is funded by the National Institute for Health Research and NHS England. The Wellcome Trust, Cancer Research UK and the Medical Research Council have also funded research infrastructure. This work was supported by the Italian Ministry of Health (RCR-2022-23682289, PNRR-MR1-2022-12376811 and RF-2021-12374963 to M.T.). Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number U01NS134358. The Barakat laboratory was supported by the Netherlands Organisation for Scientific Research (ZonMw Vidi, grant 09150172110002). K.F. was supported by Katholieke Universiteit (KU) Leuven Special Research Fund (BOF) (C14/23/121), Research Foundation – Flanders (G072921N). D.G., A.D.M., K.F. and E.T. were supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under award number R01HL161365. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funder: Italian Ministry of Health
Funder: FWO grant G072921N
Keywords
Journal Title
Conference Name
Journal ISSN
1546-1718
Volume Title
Publisher
Publisher DOI
Rights and licensing
Sponsorship
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) (U01NS134358)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research) (09150172110002)

